Pheophorbide A
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Pheophorbide A
Description :
Pheophorbide A is an intermediate product in the chlorophyll degradation pathway. Pheophorbide A can be used as a photosensitizer. Pheophorbide A is a lymphatic vascular activator. Pheophorbide A has antitumor activity. Pheophorbide A can be used for human lymphatic vascular insufficiencies research[1][2][3].UNSPSC :
12352005Hazard Statement :
H302, H315, H319, H335Target :
ApoptosisType :
Natural ProductsRelated Pathways :
ApoptosisApplications :
Cancer-programmed cell deathField of Research :
Cancer; Cardiovascular DiseaseAssay Protocol :
https://www.medchemexpress.com/pheophorbide-a.htmlPurity :
95.0Solubility :
DMSO : 2 mg/mL (ultrasonic; warming; heat to 60°C) |Methanol : < 1 mg/mL (ultrasonic; warming; heat to 60°C)Smiles :
O=C([C@@H]1/C(C(NC(/C=C2C(CC)=C3C)=C4C)=C4C1=O)=C(N=C(/C=C(C(C)=C/5C=C)\NC5=C/C3=N/2)[C@H]6C)\[C@H]6CCC(O)=O)OCMolecular Formula :
C35H36N4O5Molecular Weight :
592.68Precautions :
H302, H315, H319, H335References & Citations :
[1]Jihye Kim, et al. Pheophorbide a identified in an Eupatorium perfoliatum extract is a novel lymphatic vascular activator. Biomed Pharmacother. 2022 Mar;147:112664.|[2]Tang PM, et al. Pheophorbide a, an active compound isolated from Scutellaria barbata, possesses photodynamic activities by inducing apoptosis in human hepatocellular carcinoma. Cancer Biol Ther. 2006 Sep;5 (9) :1111-6.|[3]Ahn MY, et al. Pheophorbide a-mediated photodynamic therapy induces apoptotic cell death in murine oral squamous cell carcinoma in vitro and in vivo. Oncol Rep. 2012 Jun;27 (6) :1772-8.Shipping Conditions :
Blue IceStorage Conditions :
-20°C, 3 years (Powder)Scientific Category :
Natural ProductsClinical Information :
No Development ReportedCAS Number :
[15664-29-6]

